Oren Gilad

2022

In 2022, Oren Gilad earned a total compensation of $753.2K as President and Chief Executive Officer at Aprea Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$197,252
Option Awards$121,934
Salary$323,585
Stock Awards$110,417
Total$753,188

Gilad received $323.6K in salary, accounting for 43% of the total pay in 2022.

Gilad also received $197.3K in non-equity incentive plan, $121.9K in option awards and $110.4K in stock awards.

Rankings

In 2022, Oren Gilad's compensation ranked 3,631st out of 5,756 executives tracked by ExecPay. In other words, Gilad earned more than 36.9% of executives.

ClassificationRankingPercentile
All
3,631
out of 5,756
37th
Division
Manufacturing
2,065
out of 3,133
34th
Major group
Chemicals And Allied Products
993
out of 1,419
30th
Industry group
Drugs
930
out of 1,320
30th
Industry
Pharmaceutical Preparations
678
out of 966
30th
Source: SEC filing on July 11, 2023.

Gilad's colleagues

We found four more compensation records of executives who worked with Oren Gilad at Aprea Therapeutics in 2022.

2022

Christian Schade

Aprea Therapeutics

Chief Executive Officer

2022

Scott Coiante

Aprea Therapeutics

Chief Financial Officer

2022

Eyal Attar

Aprea Therapeutics

Chief Medical Officer

2022

Gregory Korbel

Aprea Therapeutics

Chief Operating Officer

News

You may also like